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Abstract
We performed a genome-wide scan for muscle-specific cis-regulatory modules (CRMs) using three computational prediction
programs. Based on the predictions, 339 candidate CRMs were tested in cell culture with NIH3T3 fibroblasts and C2C12
myoblasts for capacity to direct selective reporter gene expression to differentiated C2C12 myotubes. A subset of 19 CRMs
validated as functional in the assay. The rate of predictive success reveals striking limitations of computational regulatory
sequence analysis methods for CRM discovery. Motif-based methods performed no better than predictions based only on
sequence conservation. Analysis of the properties of the functional sequences relative to inactive sequences identifies
nucleotide sequence composition can be an important characteristic to incorporate in future methods for improved
predictive specificity. Muscle-related TFBSs predicted within the functional sequences display greater sequence
conservation than non-TFBS flanking regions. Comparison with recent MyoD and histone modification ChIP-Seq data
supports the validity of the functional regions.
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Introduction
A regulatory network represents the complex interplay between
regulatory proteins and biochemical processes that govern when
and where genes are expressed. Two important components of a
regulatory network are cis-regulatory modules (CRM), composed
of functionally interacting clusters of transcription factor binding
sites (TFBS) sufficient to confer a pattern of expression upon a
promoter, and the corresponding trans-acting transcription factors
(TFs) that bind to a CRM to regulate transcription initiation. The
multiple TFBS that constitute a CRM allow for combinatorial
control of expression; a limited number of TFs can participate in
an exponential number of combinations with each potentially
conferring specific patterns of gene activity [1].
CRMs can be situated almost anywhere relative to the structure
of a gene: both near and far (even exceptionally far) from the
promoter region(s) at which transcription initiates. While there are
indications of quantitative orientation effects in some cases [2],
CRMs are generally thought to be active in either direction
relative to a gene promoter. Linear distance in primary sequence is
no indication of the three dimensional distance (or orientation)
within the nucleus. Regulatory regions can be located in introns of
an adjacent gene [3,4], can skip over intervening genes [5] and
there are suggestions that CRMs can act on genes located on
different chromosomes [3,6]. Reflecting these properties, the
discovery of CRMs stands out as a significant challenge for both
computational and experimental research.
In multicellular organisms, maintaining precise spatial and
temporal control of transcription in various cell types is vital for
correct tissue development and specialization [7–9]. One of the
most widely studied ‘‘programs’’ of tissue development is the
regulation of skeletal muscle differentiation. Myogenesis is a
structured process, in which mononucleate myoblasts fuse together
to form multinucleate myotubes, which then develop into classes of
myofibres [10]. C2C12 cells provide a popular model for this
process, with an easily triggered switch between the growth and
differentiation phases [11]. Any tissue differentiation process
requires complex transcriptional regulation controls. For skeletal
muscle, differentiated cell gene expression involves at least two
major TF families, the myogenin family and the MADS family
[12–14]. In many differentiation processes, multiple proteins
within a homology-based family can participate in the regulatory
control of gene expression at overlapping temporal stages of the
process. Skeletal muscle differentiation follows this model; thus the
myogenin family may equally refer to Myogenin, MyoD, and Myf-
2 while the MADS set encompasses both Srf and multiple
members of the Mef2 gene family. Dozens of muscle-specific
CRMs have been identified [15–17], usually based on reporter
gene assays in the C2C12 cell culture myogenesis model.
Aided by the relatively plentiful set of skeletal muscle CRMs,
much effort has been made by the bioinformatics research
community to develop predictive algorithms for CRM discrimi-
nation. Multiple CRM detection programs have been developed,
which look for clusters of TFBS specific to the TFs known to be
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method to distinguish between CRM and non-CRM sequences
based on a logistic regression analysis (LRA) procedure has been
followed by a plethora of more advanced approaches (Supple-
mental Table S1 in Text S1) [15]. For example, MSCAN makes
use of motif-specific p-values to compute the statistical significance
of sets of non-overlapping potential TFBSs [18], while Clus-
terBuster is based on a hidden Markov model that incorporates
heuristics to improve predictive performance [19]. None of the
methods are sufficiently reliable for direct genome annotation; the
specificity of predictions is sufficiently low that laboratory
validation is essential to distinguish functional CRMs. The overall
performance of the methods and the properties that differentiate
the functional CRMs from the false candidates remain to be
determined.
In some cases, the prediction of CRMs has been coupled with
phylogenetic footprinting under the premise that sequence
conservation of known CRMs and TFBS is indicative of function
and therefore a conservation filter will improve the positive
predictive value of the CRM prediction methods [15,20–22]. It is
often the case that the regulatory sequences display evidence of
evolutionary selective pressure compared to the background rates
of sequence change in non-functional sequence [23,24]. If the
expression pattern of a gene is conserved between two species in
the same taxonomy class, the CRM that confers the pattern is
likely to be retained as well (although the individual TFBS within
the CRM may be altered). By applying phylogenetic footprinting
to the analysis of closely related species (i.e. 50–100 million years
of separation for vertebrates), it becomes possible to concentrate
predictions within a subset of regions in the conserved segments of
genes. Improved specificity is balanced against the reduced
sensitivity imposed by any filter.
Once predictions of regulatory sequences have been made,
laboratory validation is required to confirm regulatory function.
One of the most widely used methods for validating computational
predictions of regulatory regions are reporter gene assays in a cell
culture model system [25]. A fusion construct of the predicted
regulatory sequence and a reporter gene with a basal promoter in
a plasmid is transiently transfected into cells, and the reporter gene
activity is measured to determine the regulatory impact that the
tested sequence exerts. It is feasible to conduct larger-scale
experiments to investigate functional properties of panels of
candidate CRMs and promoters within cells. Cooper et al
performed a large screen of promoter activity in 16 cell lines on
all predicted promoters in the 1% of the human genome targeted
for in depth annotation by the ENCODE Project [26]. Similarly,
relatively large-scale in vivo enhancer studies have been performed
using highly conserved (human to fish) sequences driving reporter
gene expression in transgenic mouse embryos, leading to the
identification of 75 forebrain-specific enhancers [27]. Kappen et al.
analyzed the regulatory controls for lsl, a LIM/homeodomain
transcription factor, by inserting randomly sheared 8–10 kb
fragments from the lsl genomic locus into reporter constructs
and testing for expression both in vitro and in vivo [28]. Using a
single copy insertion mouse transgenesis procedure, the Pleiades
Promoter Project evaluated over 100 candidate regulatory
sequences for the capacity to direct selective patterns of reporter
gene expression in the developed brain [29]. The development of
higher-throughput approaches to verify enhancer and promoter
function has been a focus of recent efforts to annotate vertebrate
genomes.
The properties of skeletal muscle CRMs have been widely
studied, but relatively few novel functional CRMs have been
described since CRM prediction methods have emerged. To
quantify the performance of CRM prediction methods requires a
new body of reference data. We generated predictions of CRMs
with three published methods and assessed the predictive benefit of
sequence conservation and annotation of the expression patterns
of proximal genes. We employed LRA, MSCAN, and ClusterBus-
ter to scan the human genome for putative skeletal muscle
regulatory regions, and tested a subset for the capacity to drive
reporter gene expression in a selective manner in the C2C12 cell
skeletal muscle differentiation assay. We compare the reporter
gene expression in immature myoblasts against expression in
mature myotubes, as well as in a fibroblast cell line. Based on the
outcomes of the analysis, we define additional properties of
sequence composition that are predictive of function and establish
a new reference collection for the continuing development of
predictive methods.
Methods
Human Genome Search Regions
Promoter regions are identified following the procedure
described for the oPOSSUM database [30]. The oPOSSUM
database contains the set of genes identified as being in one-to-one
human and mouse ortholog pairs based on annotations in
EnsEMBL v. 41 and UCSC hg18/mm8 whole genome align-
ments. For each ortholog pair, 10 kb upstream and downstream of
a TSS is searched for CRMs. All noncoding regions are included
in the search, including intergenic regions, introns, and untrans-
lated regions (UTR) of exons; protein coding portions of exons are
excluded. Any noncoding region that constitutes a portion of a
coding exon in an alternative transcript is removed from the
selection process. All alternative transcription start sites (TSS)
supported by either human or mouse Fantoms3 CAGE evidence
were identified and 50 bp on either side of each TSS was excluded
[31].
Muscle cis-Regulatory Module Prediction
CRM prediction tools were used to search for muscle-specific
regulatory modules within the specified genome sequences.
Logistic Regression Analysis (LRA), MSCAN, and ClusterBuster
were applied to the human genomic sequence regions specified
above [15,18,19]. The input TFBS motif models were taken from
JASPAR, a database of transcription factor binding site profiles
Author Summary
For efficient identification of genomic sequences respon-
sible for regulating gene expression, a number of
computer programs have been developed for automatic
annotation of these regulatory regions. We searched for
potential regulatory regions responsible for controlling the
expression of skeletal muscle-specific genes using these
programs, and validated the predictions in a popular cell
culture model for muscle. We were able to identify 19
previously uncharacterized regulatory regions for muscle
genes. The accuracy of the predictions made by these
programs leaves much to be desired, leading us to
conclude that other signals in addition to the sequence
information will be required to achieve sufficient predic-
tive power for genome annotation. Genomic regions with
confirmed regulatory function were compared against
non-functional sequences, revealing sequence conserva-
tion, composition and chromatin modification properties
as important signals in determining regulatory region
functionality.
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MYF (MA0055), TEAD (MA0090), and SP1 (MA0079); TFs with
described key roles in muscle-specific gene expression. Predicted
CRMs composed entirely of SP1 TFBS were excluded.
Conservation Analyses
The candidate regions were analyzed for conservation based on
phastCons scores (generated with 28 placental mammal genomes)
obtained from the UCSC Genome Annotation system [33]. For a
region to be classified as conserved, the presence of at least one
sub-region with phastCons scores of 0.7 or greater over 20 bp is
required. For each region, both the mean and the maximum
phastCons scores were calculated and sub-regions with phastCons
scores over 0.7 were extracted and the ratio of the length of these
sub-regions over the total length of the region calculated. For
phylogenetic depth evaluation, three sets of human phyloP scores
(generated with 46 vertebrates, 46 placental mammals and 46
primates; database version hg19) were obtained from the UCSC
Genome Annotation system.
MyoD ChIP-Seq Data
The ChIP-Seq peak locations for MyoD binding regions in the
mouse genome were obtained from http://www.cs.washington.
edu/homes/ruzzo/papers/DevCell/2010a/, the companion web
resource to the reference publication [34].
Histone Modification ChIP-Seq Data
C2C12 cell ChIP-Seq peak locations for H3K4me1/2/3,
H3K9me3, H3K9Ac, H3K18Ac, H3K27me3, and H4K12Ac
annotated by Asp et al. were downloaded from the NCBI GEO
database (GSE25308; [35]).
TFBS Profile Similarity Comparison
MatrixAligner was used to calculate the profile similarity of two
TFBSs [36]. This program generates scores from 0 to 2, where a
score of 2 indicates complete identity between two matrices being
compared.
Cell Culture
Mouse C2C12 myoblasts (ATCC CRL-1772; American Type
Culture Collection; Manassas, VA, USA) and mouse NIH-3T3
fibroblasts (ATCC CRL-1658; American Type Culture Collec-
tion; Manassas, VA, USA) were maintained in Dulbecco’s
modified Eagle’s medium, supplemented with 10% (v/v) heat
inactivated fetal bovine serum, 100 U/ml penicillin, and 100 mg/
ml streptomycin. The cultures were grown at 37uC and 5% CO2.
Differentiation of myoblasts into myotubes was induced by
transferring C2C12 cells to differentiating media consisting of
2% (v/v) horse serum, 100 U/ml penicillin, and 100 mg/ml
streptomycin. The media and reagents for cell culture were
obtained from Gibco-Invitrogen (GIBCO-Invitrogen Canada,
Canadian Life Technologies, Burlington, ON, Canada).
Plasmids and Cloning
Primer3 was used to design the flanking primers for each
predicted CRM for PCR [37]. After performing PCR with the
designed primers (synthesized by Invitrogen Coporation (Carls-
bad, CA, USA)), 20 ng of each PCR product was pooled, which
were then purified using the PCR purification kit (NEB,
Mississauga, ON, Canada) and subcloned into the pGL-3
promoter luciferase vector (Promega; Fisher Scientific, Nepean,
ON, Canada) via Kpn I and Bgl II restriction enzymes sites.
Restriction digest was performed overnight at 37uC. Post-
digestion, the vector was dephosphorylated with calf intestinal
alkaline phosphatase (NEB, Mississauga, ON, Canada). The
restriction enzyme-digested PCR products and the vector were
gel-purified using QIAquick gel extraction kit (Qiagen Inc.
Mississauga, ON, Canada) and ligated using T4 DNA ligase
(NEB, Mississauga, ON, Canada).
A set of control clones and a sample of the library were
prepared. Constructs were transformed into sub-cloning efficient
DH5a chemically competent E .coli cells (GIBCO Invitrogen
Canada, Canadian Life Technologies, Burlington, ON, Canada)
via heatshock at 42uC and plated on LB agar plates containing
100 mg/ml of Ampicillin for preliminary bacterial colony screen-
ing. Colonies were picked and inoculated overnight in 3 ml LB
broth with ampicillin. Plasmids were prepared using QIAprep
Spin Miniprep Kit (Qiagen Inc. Mississauga, ON, Canada).
Sequence confirmation was performed by the CMMT/CFRI
DNA Sequencing Core Facility.
High-throughput Screening of Clone Libraries
Large-scale transformation, colony picking, miniprep, and
sequencing reactions with the constructs were performed (Genome
Science Centre, Vancouver, BC, Canada). 1 ml of ligation mix was
transformed by electroporation into E. coli DH10B T1 resistant
cells (Invitrogen). Transformed cells were recovered using 1 ml of
SOC medium and plated onto 22 cm622 cm agar plates
(Genetix) containing 100 ug/ul ampicillin. Bacterial colonies were
picked from the agar plates and arrayed into 384-well microtiter
plates (Genetix) using a QPIX automated colony 15 picker
(Genetix). Plasmid preparations were performed via an alkaline
lysis protocol. DNA sequencing reactions were prepared using a
Biomek FX workstation (Beckman-Coulter) and performed using
BigDye 3.1 (Applied Biosystems). Analysis of the resulting
sequences to the target DNA regions was performed with AlignX
from the Vector NTI software (Invitrogen).
DNA Concentration Measurement and Normalization
Concentration of the plasmid products was quantified using
Picogreen assays (GIBCO-Invitrogen Canada, Canadian Life
Technologies, Burlington, ON, Canada) via fluorescence mea-
surement with a POLARstar Omega microplate reader (BMG
Labtech; Fisher Scientific, Nepean, ON, Canada). All DNA
samples were normalized to 100 ng/ml per well.
Transfection and Reporter Gene Assays
Two sets of C2C12 myoblasts and one set of NIH-3T3
fibroblasts were seeded in 96-well plates at a density of 6000 cells
per well. The myoblasts were divided into two sets so that one set
could be harvested as myoblasts, while the other set could be
differentiated into myotubes prior to harvest. After 24 h (at 70%
confluency) in growth media, the cells were transfected with
200 ng of a pGL3-promoter firefly luciferase plasmid construct
and 20 ng renilla phRL-TK internal control luciferase plasmid
(Promega, Madison, WI) using Lipofectamine 2000 according to
the manufacturer’s protocol (GIBCO-Invitrogen Canada, Cana-
dian Life Technologies, Burlington, ON, Canada). At 24 h post-
transfection, the myoblast C2C12 set and the NIH-3T3 fibroblasts
were harvested and luciferase activity measured using the Dual-
Luciferase Reporter Assay System (Promega, Madison, WI) and a
POLARstar Omega microplate reader (BMG Labtech; Fisher
Scientific, Nepean, ON, Canada). The final set of C2C12
myoblasts was switched to differentiating media 24 h after
transfection, and incubated for 96 h for differentiation into
myotubes. For each clone, duplicate transfections (technical
replicates) were performed. The reporter gene activity assays were
Muscle Enhancer Profiling Reveals Novel Properties
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tested in the three cell types. In the second phase, only myotube
and myoblast activities were assessed.
Data Analysis
The following terminology will be used when discussing the
experimental data:
N Clone: a single clone bacterial colony with a homogeneous
insert sequence
N Plasmid prep: plasmid extraction from a single bacterial
culture
N Insert sequence: the genomic region introduced into a plasmid
N Insert plasmid: the vector plasmid containing a sequence of
interest
N Clone replicates: replicated experiments using the plasmids
from the same clone but from different plasmid preps (i.e.
independent DNA preparation)
N Insert replicates: experiments using plasmids recovered from
different bacterial clones but sharing the same insert sequence
N Technical replicates: replicated experiments using plasmids
from the same DNA preparation
All statistical analyses were done using the R software [38]. The
ratios of firefly luciferase expression values over the renilla
luciferase expression values were calculated to measure the relative
increase of the firefly luciferase activity over the renilla luciferase
activity (the internal control for transfection efficiency). Clones that
did not produce both firefly and renilla luciferase expression values
above the minimum threshold of 1000 luminescence relative light
units (LRUs) were marked as failed transfections and removed
from subsequent analyses. This heuristic filter was applied to
exclude spurious expression ratio measurements, as the ratio of
two small values can result in a disproportionately high value, and
the VSN procedure intended to mitigate this effect was not
sufficient [39]. For those clones where only the firefly luciferase
values were above this threshold, the renilla luciferase value was
set to the threshold level. This step was designed to minimize the
occurrence of large ratios even when the firefly luciferase
expression values are near the threshold. The threshold of 1000
LRUs is higher than the median machine background level, which
was found to be below 250 LRUs. While this conservative heuristic
filter may result in a decrease in sensitivity, the trade-off was
deemed acceptable in order to avoid situations where spurious
measurements are accepted as false positive results. The expression
ratios from the two technical replicates for each clone were
averaged, excepting the cases where a replicate transfection failed
the minimum expression threshold filter (in such cases the single
replicate value was used). The expression ratios obtained for each
cell type were normalized using the VSN package. Each clone was
treated as an independent sample even though there were in some
cases insert replicates. The stochastic variation in the number of
insert replicates would otherwise have complicated the analysis.
Differential expression between 1) fibroblasts and myotubes, 2)
myoblasts and myotubes, and 3) fibroblasts and myotubes groups
were determined using the SAM package [40], applying a false
discovery rate maximum of 0.05. The two sets of clones selected
from phase 1 and phase 2 at the FDR of 0.05 were combined and
grouped according to the insert sequence. For each sequence, the
Figure 1. Selection of clones for differential expression analysis. The selection is divided into 2 phases, where the clones selected for Phase 2
are a subset of all clones tested in Phase 1. Phase 1 and Phase 2 samples are from different plasmid preparations.
doi:10.1371/journal.pcbi.1002256.g001
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expression was counted, and those sequences with only one
supporting clone and/or less than 50% of the available clones
identified as positive were excluded from the final set.
Results
The experimental procedures and analyses presented in this
paper consist of four main components: i) computational
prediction of muscle-specific CRMs within the human genome;
ii) validation of predictions using reporter gene assays and cell
culture; iii) assessing performance of CRM prediction tools on the
experimentally tested regions; and iv) analysis of the properties of
newly validated muscle-specific CRMs relative to the properties of
non-active sequences.
Region Selection
The overall region selection process is illustrated in Supple-
mental Figure S1 in Text S2. Three sets of genomic sequences
were identified for the study of skeletal muscle CRM predictions:
(i) background regions randomly selected from conserved regions
for control (background set); (ii) predicted skeletal muscle CRM
regions proximal to skeletal muscle-expressed genes (muscle set);
and (iii) predicted skeletal muscle CRM regions proximal to genes
with no observed link to skeletal muscle (non-muscle set). Prediction
of CRMs was performed for the muscle and non-muscle sets, while
the background sequences were randomly selected from conserved
intergenic regions which may or may not contain predicted
CRMs. The sets are further described below.
Background. A set of 200 regions was selected randomly
from intergenic regions within the oPOSSUM conserved
sequences (Methods) with high regulatory potential scores [41].
The scores are intended to reflect consistency with the pattern of
sequence identity in genome sequence alignments observed in
known CRMs, and minimally reflect regions of greater sequence
conservation. It is important to note that regions selected from
conserved regions of the genome are likely to have distinct
properties from regions randomly selected from the whole
genome.
Muscle. Gene expression profiles associated with elevated
expression concurrent with C2C12 myoblast-to-myotube differen-
tiation were identified from the literature. Distinct sources of
annotated skeletal muscle genes follow. Moran et al. performed gene
expression profiling using Affymetrix oligonucleotide arrays, and
identified 108 genes up-regulated in differentiated myotubes using
one-way nested analysis of variance [42]. Tomczak et al. profiled
expression using Affymetrix GeneChips, from which they identified
447 genes up-regulated in myotubes through hierarchical cluster
analysis with CAGED 1.1 software [43]. In a complementary study,
Blais et al. performed ChIP-chip analysis that identified 198 regions
bound by MyoD, myogenin or Mef2 [44]. Kislinger et al. examined
global proteome changes by tracking the abundance of 1865
proteins through gel-free tandem mass spectrometry in both
myoblasts and myotubes, of which 80 were identified as up-
regulated in myotubes [45]. The superset of the skeletal muscle
genes arising from these studies was compiled. We previously
annotated a list of 28 CRMs in 24 human genes for which at least
one regulatory region responsible for skeletal muscle expression had
Table 1. List of genomic regions validated as driving muscle-specific expression.
Coordinates Prediction Method
Set Chr Prediction Insert Gene Name
Positive
Wells C. Buster LRA MSCAN
BG 11 116201218–116201584 116201218–116201584 APOA4; APOC3 4/5
BG 11 1721407–1721765 1721407–1721765 HCCA2 3/6 C
BG 11 66008803–66009164 66008803–66009164 DPP3 2/2
BG 11 71615350–71615709 71615350–71615709 INPPL1 2/2
NM 15 83185168–83185457 83184998–83185491 ALPK3 2/2 C L M
NM 18 40637176–40637555 40637097–40637579 SETBP1 3/4 C L M
NM 22 22516591–22516990 22516569–22517062 DERL3; SLC2A11 10/11 C L M
NM 22 22883635–22883974 22883584–22884017 CABIN1 2/4 C L M
M 1 119250477–119250882 119250477–119250882 TBX15 2/2 C L M
M 1 199612030–199612429 199611961–199612457 TNNT2 2/4 C M
M 2 144878638–144878867 144878533–144878970 ZEB2 2/2 C M
M 2 88147937–88148156 88147915–88148315 SMYD1 4/4 L
M 4 37728510–37728799 37728494–37728957 TBC1D1 2/4 L M
M 6 42106432–42106831 42106373–42106867 CCND3 2/2 C L M
M 6 7127465–7127684 7127364–7127817 RREB1 2/4 L M
M 9 35677988–35678317 35677887–35678364 TPM2 6/9 C L
M 14 104259446–104259775 104259362–104259861 INF2; ADSSL1 2/3 C L
M 19 3326530–3326884 3326530–3326884 NFIC 4/4 L M
M 19 54184895–54185244 54184834–54185225 GYS1 2/3 C L M
Gene names were chosen for their proximity to the regions of interest (UCSC hg18). ‘Positive Wells’ column shows the number of replicates that were classified as
positive out of all replicates for the sequence. Columns ‘C.Buster,’ ‘LRA,’ and ‘MSCAN’ indicate programs which predicted a CRM in the given region.
doi:10.1371/journal.pcbi.1002256.t001
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musclereference set(aportionofthissetwasdescribed in[15];listed
in Dataset S1). Combining the superset with the muscle reference
set yields 610 unique skeletal muscle-selective genes based on
C2C12 experimental data.
Three CRM prediction programs were applied to the 610
sequences and 2,167 putative CRMs were recorded. A total of 518
candidate regions were predicted by more than one program, and
high-quality primers for the same experimental PCR settings could
be designed for 271 of them using Primer3. Further 220 primers
could be designed for 400 randomly selected putative CRMs that
were predicted by one program only. In the end, 384 candidate
regions were selected for PCR amplification. For the muscle
reference set, albeit highly circular due to the use of most of the
sequences in parameter training for the published methods, we
assessed the number of known CRMs detected by each program:
Cluster-Buster detected 16, LRA detected 13, and MSCAN
detected 10.
Non-muscle. The set of genes represented in the oPOSSUM
database excluding the 610 muscle genes were similarly scanned
with the three prediction tools. These candidate CRMs were
screened to remove any overlap with CRMs included in the muscle
set or the background set.
Validation of CRM Activity in Cell Culture
Library construction and properties. The above sets of
predicted CRMs and background regions were inserted into
luciferase reporter gene plasmids and prepared as clone libraries.
As the clone recovery process was stochastic, only a subset of the
regions was recovered from each library and the number of insert
replicates for each candidate CRM was variable. In the end, 355
unique insert sequences were present in 672 tested plasmids, of
which 339/355 were successfully aligned to the intended PCR
regions. The specific number of recovered candidate regions from
each collection (88 background, 196 muscle or 55 non-muscle) is given
in Supplemental Table S2 in Text S1; their locations are listed in
Dataset S1. A brief discussion on the technical challenges faced is
given in Text S3.
Validation of the assay. Before proceeding with the
experimental validation of the 339 sequences, we first assessed
the performance of the dual luciferase reporter assay with known
CRMs from muscle-expressed genes (desmin, TN-I) [46–48] and
non-muscle expressed genes (PAH) [49]. The activity of the pGL3-
promoter plasmid served as a negative control, while the PAH
sequence was anticipated to function equivalently in differentiated
and undifferentiated C2C12 cells. Two independent plasmid
preparations were assessed with transfections performed in
triplicate. The expression of the reporter gene driven by the
muscle CRMs was elevated 5-fold (DES) and 15-fold (TNI) in
myotubes relative to myoblasts, while the non-muscle CRM (PAH)
was unchanged (Supplemental Figure S2 in Text S2).
Reporter expression analysis. An overview of the clone
production process is presented in Figure 1. The subset of plasmids
that selectively directed myotube expression (2-fold increase or
elevated based on SAM analysis) in phase 1 was advanced for
further analysis in phase 2. In addition, single rows from each of
the seven plates used in phase 1 were advanced, in order to assess
the reproducibility of results. This selection process resulted in 204
plasmids being advanced. Independent plasmid preparations were
used in the second round.
While individual predicted CRM inserts exhibit higher
expression than the background controls, the mean expression
ratios of the two sets are not significantly different based on a t-test
(Supplemental Figure S3 in Text S2). Reporter gene expression
increases from myoblasts to myotubes are similar between the two
groups, although the predicted CRM inserts exhibit higher
variability. Both firefly and renilla raw reporter expression values
were lower for the background controls. This characteristic was
observed for both phase 1 and phase 2 (independent plasmid
preparations).
Using the analysis criteria described in Methods, a set of 19
novel insert sequences was identified as driving selective
m y o t u b ee x p r e s s i o n( r e l a t i v et om y o b l a s t sa n df i b r o b l a s t s )
(Table 1). These 19 CRMs are hereafter referred to as the
validated positive regions. Of the 19 CRMs, 11 were derived
f r o mt h em u s c l eg e n ei n s e r ts e t ,4f r o mt h en o n - m u s c l es e ta n d
4 from the conserved regions control group. Application of the
CRM prediction tools to the 4 functional sequences from the
control group resulted in 1 putative CRM being identified by
ClusterBuster.
Table 2. Over-represented TFBS in the background regions of the validated set vs. the non-responding background regions
(ranked by Fisher p-values).
TF TF Class Ctrl gene hits Ctrl gene non-hits Target gene hits Target gene non-hits Z-score Fisher score
RREB1 ZnF-C2H2 8 43 3 1 13.29 2.23E-02
Dl REL 26 25 4 0 5.27 8.04E-02
NHLH1 bHLH 16 35 3 1 7.03 1.14E-01
doi:10.1371/journal.pcbi.1002256.t002
Table 3. Over-represented TFBSs in the non-background regions of the validated set vs. the non-responding non-background
regions (ranked by Fisher p-values).
TF TF Class Ctrl gene hits Ctrl gene non-hits Target gene hits Target gene non-hits Z-score Fisher score
MEF2A MADS 116 92 13 2 4.48 1.55E-02
NHLH1 bHLH 120 88 12 3 7.98 7.36E-02
Fos bZIP 181 27 15 0 4.10 1.35E-01
doi:10.1371/journal.pcbi.1002256.t003
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To identify defining characteristics of the positive regions
compared to the non-responding regions, the validated set was
subjected to analyses based on sequence and conservation
properties.
Overrepresented TFBS. The oPOSSUM analysis method
was applied to identify TF binding motifs over-represented in the
19 functional CRMs relative to the inactive inserts (Table 2). The
top-scoring TFBS in the myotube-directing background regions
are those of RREB1, dorsal and NHLH1 [50–52]. We could not
find any direct link between muscle development and RREB1 in
the literature. It is possible that the enrichment is just an artefact
due to the RREB1 motif having high information content, which
results in infrequent binding site predictions compared to most
other motifs. If the foreground regions contain even just a few sites,
it can result in high over-representation scores compared to the
background set. Dorsal, a Rel TF, is involved in early stages of fly
development; however, we could not find any direct role that Rel
TFs play in vertebrate muscle development. As there could be
other contributing motifs beyond the 5 muscle-linked motifs used
the initial CRM prediction methods, further oPOSSUM analyses
were carried out: 1) comparing the validated regions from the non-
background sets as the test set against the remainder of the non-
responding regions of the non-background sets as the control set,
and 2) comparing the entire set of validated regions against all
inactive inserts. Because all non-background regions are CRM
predictions made with the 5 muscle motifs, these motifs were
expected to be prevalent in both the positive and non-responding
regions. Unexpected motifs present in the positive regions but
absent in the non-responding regions could contribute to increased
expression in myotubes. If this were the case, these additional
motifs would be expected to be overrepresented in the above
oPOSSUM analyses. Comparison of the non-background
validated regions against the non-responding regions returned
MEF2A and NHLH1 as being the most over-represented TFs
(Table 3). MEF2A is one of the five muscle TFs used to make the
CRM predictions. As not all predictions necessarily contain
MEF2A hits, this result indicates the importance of this binding
site being present for functional muscle-specific CRM relative to
the other four muscle motifs. It suggests that MEF2 binding sites
are potential master sites for a subset of active CRMs. NHLH1 is a
bHLH TF, the same TF class as the myogenin family, sharing a
similar binding profile with this group (normalized score of 1.73
using the MatrixAligner program, as explained in the Methods
section). The over-representation of this motif may be an indirect
marker for Myf, one of the five profiles contributing to the CRM
predictions. Comparison of all validated regions against all non-
responding regions again returns NHLH1, RREB1 and MEF2A
as the most over-represented motifs (Table 4; Supplemental Figure
S4 in Text S2).
Sequence composition. The next property examined was
the sequence composition of the validated regions. Specifically, we
analyzed both the single and dinucleotide composition
characteristics of these regions to see if any significant biases
could be found compared to the non-responding regions. The
Wilcoxon rank sum test was performed to determine if any of these
region sets showed significantly different composition
characteristics. As shown in Table 5, both the muscle validated
regions have higher G/C mononucleotide frequency compared to
the non-responding regions; the significance of these differences is
supported by the rank sum tests for which most p-values were
below 0.05.
We also calculated the G/C and A/T skews in these sequences,
but no significant differences in these two measures could be found
between the responding regions and the non-responding regions
(Supplemental Table S3 in Text S1).
To further characterize the sequence compositional differences
between the responding and the non-responding regions, we
analyzed the dinucleotide compositions of the sequences
(Figure 2a). Differences were found in the frequencies of AA,
CC and GG, where the responding regions have higher
frequencies of CC and GG dinucleotides, and the non-responding
regions have higher frequencies of AA dinucleotides. This gives
further support to the difference in the G/C compositional
characteristics of the responding vs. non-responding regions. The
CpG dinucleotide was not enriched in the validated regions and
analysis presented below suggests that the enrichment properties
are not related to the well-known properties of CpG islands (this
point will be further explored below).
To examine whether such biases are present in CRM regions
for other tissue types, we performed composition analyses of the
curated brain-specific CRM collection from the Pleiades Promoter
Project [29]. The goal of this project is to construct human mini-
promoters that drive gene expression in specific brain regions. As
part of this project, the authors compiled a set of regulatory
sequences from 296 genes shown to act as brain-specific CRMs in
literature, which they deposited into the PAZAR database [53].
They also performed in vivo expression studies of their mini-
promoter constructs to identify the regulatory sequences that can
drive gene expression specifically in brain regions. Because this
data set is comprised of sequences from a number of different
species, we performed our analysis on both the entire set and
Table 4. Over-represented TFBSs in all regions of the validated set vs. the non-responding regions (ranked by Fisher p-values).
TF TF Class Ctrl gene hits Ctrl gene non-hits Target gene hits Target gene non-hits Z-score Fisher score
NHLH1 bHLH 136 123 15 4 9.79 2.07E-02
RREB1 ZnF-C2H2 50 209 8 11 11.49 2.49E-02
MEF2A MADS 125 134 13 6 3.38 7.16E-02
doi:10.1371/journal.pcbi.1002256.t004
Table 5. Sequence composition characteristics of the
responding regions vs. non-responding regions.
Responders Non-Responders p-value
Muscle Validated 0.54 0.51 4.35E-02
Muscle Reference 0.58 0.51 2.87E-06
Pleiades Curated All 0.55 0.51 1.67E-02
Pleiades Curated Human 0.56 0.51 3.40E-03
GC content; P-values were calculated using Wilcoxon rank sum tests.
doi:10.1371/journal.pcbi.1002256.t005
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use the non-coding human sequences that were tested in the
project and found to have no effect on driving gene expression in
the mouse brain. Similar to the muscle sequences, the Pleiades
brain CRMs display elevated G/C content compared to non-
functional sequences (Table 5). As for the dinucleotide frequencies,
while not as pronounced in the muscle responders vs. non-
responders, for the Pleiades regions, TA, TG and TT dinucleo-
tides occur more frequently in the non-responders (Figure 2b).
Lastly, we repeated the analysis for the MyoD ChIP-Seq peak
locations identified by Cao et al., and found elevated G/C content
in the MyoD-binding regions (Table 6).
Evidence of muscle expression. We attempted to assess if
myotube expression data was predictive for functional CRM
activity in the results (Supplemental Table S4 in Text S1), however
there were insufficient numbers from most datasets to determine
significance.
Sequence conservation. In selecting candidate skeletal
muscle CRMs, we did not incorporate phylogenetic footprinting
(sequence conservation). This exclusion allows for a retrospective
assessment of the impact of conservation-based filters on the
specificity and sensitivity of the predictions. Table 7 gives the
comparison of the sequence conservation characteristics of the
validated regions versus the non-responding regions. While the
average lengths of the PCR amplified inserts averaged ,400 bp,
only a portion of each sequence may be conserved. Global
measures may therefore fail to reflect the presence of a locally
conserved putative CRM. To alleviate this potential problem, we
measured both the mean and the maximum sequence
conservation scores for each region and then calculated the
mean of these values for each region set. For the validated regions
from the non-background sets, we observe both higher mean and
maximum phastCons scores compared to the non-responding
regions. This observation supports the validity of the widely used
approach of applying conservation filters when making predictions
for functional genomic regions. While some genome-wide ChIP-
Seq studies for TFs have suggested that the conservation of the TF
binding regions are limited, it is important to recognize that the
TF binding by itself does not necessarily indicate cis-regulatory
function. Figure 3 presents examples of positive regions from each
of the background, non-muscle and muscle sets, representing the
different conservation characteristics observed. The performances
of the three methods with and without sequence conservation filter
are summarized in Supplemental Table S5 in Text S1.
We performed receiver operating characteristic (ROC) analysis
for Cluster-Buster, LRA, and MSCAN using the ROCR package
in R [54]. The ROC analysis was performed both with and
without a conservation filter applied, based on the maximum
phastCons scores (Supplemental Figure S5 in Text S2). For true
positive regions, we included both the insert sequences that were
validated through the reporter expression assays or literature-
derived known muscle reference regions exclusive of the skeletal
muscle training sets used in the development of LRA and
ClusterBuster (see Dataset S1). For negative examples, all
predicted and tested CRM regions (muscle and non-muscle sets) that
did not respond to the reporter assays were used. An ROC curve
based solely on the conservation filter was also generated. While
adding the conservation filter improved the prediction perfor-
mance for all methods tested, the conservation filter-only results
exhibited the best performance, with the AUC of 0.76. However,
it is noted that a large percentage of the non-responding regions
come from the predictions by the three methods (211 of 295
regions, or 71.5%); as such, this high AUC of 0.76 is not
independent of the contributions by the prediction programs. The
findings confirm utility for incorporating sequence conservation
into the prediction of cis-regulatory modules.
Promoters and CpG islands. We examined the distances of
the regions to the nearest Ensembl-annotated TSSs (Supplemental
Table S6 in Text S1). While there was much variability in the
distances, with some regions located more than 100 kb away, the
responding regions were in general located closer to the TSSs than
the non-responding regions (median of ,1 kb vs. ,12.5 kb). In
order to determine if the responding regions are associated with
CpG islands, 1 kb upstream and downstream from each region
were searched for UCSC-annotated CpG islands (Supplemental
Table S7 in Text S1). While a higher proportion of the responding
regions were associated with CpG islands compared to non-
responding regions, the difference did not have statistical
significance (p-value of 0.13 obtained with Fisher test). Only 2
regions from the validated set were associated with CpG islands
(10.5%), while 10 regions from the reference set overlapped with
CpG islands in their flanking sequences (35.7%). This increase is
likely due to the fact that the reference set regions are more
proximal to the TSSs (median distance of 122.5 bp) than the
validated set regions (median distance of 4,606 bp), and CpG
islands are also typically in the vicinity of TSSs [55]. As evident in
Table S7 in Text S1 and Figure 2, the muscle reference regions do
display elevated CpG frequency and CpG island proximity,
consistent with experimental bias in early promoter analysis for
regions proximal to transcription start sites.
Phylogenetic depth. Cheng et al. performed ChIP-chip
analysis of GATA1 binding regions in mouse erythroid cells and
observed that most of the GATA1 binding regions contained the
canonical binding site motifs [56]. However, they determined that
the GATA1 binding motifs in regions associated with high
enhancer activity were more evolutionarily conserved compared
to those motifs in regions with no identifiable enhancer activities.
To evaluate whether this observation holds for the muscle
regulatory regions identified in this study, we searched the three
region sets for binding site hits with all available vertebrate profiles
Figure 2. Dinucleotide frequencies in responding regions vs. non-responding regions. a) Muscle Regulatory Regions. Muscle
Validated=19 validated muscle regions in this study. Muscle Reference=28 muscle reference regions from literature. Muscle Non-Responders=all
regions that were tested in this study and found not to drive gene expression. b) Pleiades Curated Regulatory Regions. Pleiades Curated All=1341
curated regulatory regions from all species. Pleiades Curated Human=631 curated regulatory regions in humans only. Non-Responders=all regions
that were tested and found not to drive gene expression.
doi:10.1371/journal.pcbi.1002256.g002
Table 6. Sequence composition characteristics of the MyoD
ChIP-Seq peaks compared against the non-responding
regions from this study.
MyoD ChIP-Seq Non-Responders p-value
Myotube 0.54 0.51 1.23E-06
Myoblast 0.54 0.51 6.60E-07
GC content; P-values were calculated using Wilcoxon rank sum tests.
doi:10.1371/journal.pcbi.1002256.t006
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the same motif were found, only the highest scoring site was kept.
We first calculated the average phyloP scores for the predicted
binding site and non-binding site positions in each of the three
region sets. The scores for the responding regions are spread over
a larger range than the non-responding regions, which also
showed the lowest mean score (Supplemental Figure S6 in Text
S2). We identified the TFs with predicted binding sites that
exhibited at least 2-fold increase in their phyloP scores over the
non-binding site positions in each region set, and compared the
mean phyloP scores in the predicted sites for these TFs among the
three region sets (Supplemental Table S8 in Text S1). The average
phyloP scores were significantly higher for the validated and
reference sets than for the non-responding set, as confirmed by t-
tests. Included in the TFs with 2-fold increase in the validated and
reference sets are some of the known muscle-specific TFs, such as
MEF2A, Myf, SRF and PBX1 [57]. We combined the list of the
TFs with at least 2-fold increase in the validated and the reference
set, and compared the ratios of the phyloP scores for the predicted
sites for these TFs and the non-binding site positions in each
region set (Figure 4). The ratios are significantly higher for the
responding regions (confirmed with t-test; p-value of 2.4610
24 for
all species; Supplemental Table S8B in Text S1). When phyloP
scores are calculated using more closely related species, the p-
values become more significant. Non-responding regions do not
show such a trend in scores (confirmed with t-test; p-value of 0.76
for all species and primates only).
MyoD ChIP-Seq evidence. Cao et al. performed a genome-
wide ChIP-Seq binding assay for MyoD in C2C12 myoblasts and
myotubes [34]. We compared the MyoD peak locations with our
three region sets to determine the extent of overlap with each. As
we were testing the regulatory effects of human genomic sequences
in murine C2C12 cells, we first performed a lift-over of the regions
to the mouse genome using the Galaxy service, transitioning from
human assembly hg19 to mouse assembly mm9 [58]. Successfully
mapped regions were then compared with the MyoD peak
locations (Table 8). Whereas only 15.6% of the successfully
mapped non-responding regions overlapped with the MyoD peaks
in myotubes, 58.1% of the responding regions overlapped with the
peaks, which is a significant increase (p-value=3.0610
28 with
Fisher exact test). These observations support the use of ChIP-Seq
assay results for achieving improved specificity in the identification
of functional regulatory elements.
Histone modifications. Chromatin conformation changes
through histone modifications play an important role in the
regulation of gene expression. Acetylation of histone tail residues
lead to open chromatin, allowing TFs better access to enhancer
regions. Histone methylation has been associated with both
activation and repression depending on which residues are
modified. In order to examine the epigenetic changes associated
with myotube formation, Fischer et al. performed a ChIP-chip
study of major histone modifications (H4ac, H3ac, H3K4me2/3)
in C2C12 cells, from which they observed that H3K4me2 (when
combined with other acetylation in the same region) and H4ac
were frequently associated with elevated expression [59]. Asp et al.
performed a more comprehensive ChIP-Seq study in C2C12 cells,
where they identified the locations of H3K4me1/2/3, H3K9me3,
H3K9Ac, H3K18Ac, H3K27me3, H4K12Ac, and PolII in both
myoblasts and myotubes [35]. Using the subsets of the validated,
reference and non-responders that were successfully mapped to
the mouse genome, we examined the extent of overlap between
these regions and the modified histone peaks for H3K4me1/2/3,
H3K9Ac, H3K18Ac, H3K27me3 and H4K12Ac (Figure 5). We
observed increases in the proportion of the combined set of
responding regions that overlapped with H3K4me2 (p-
value=3.5610
26 with Fisher exact test), H3Kme3 (p-
value=2.7610
25), and H3K18ac (p-value=3.4610
23) peaks in
myotubes compared to myoblasts, whereas the non-responding
regions did not show as large increases (p-values for H3K4me2:
6.5610
23, H3Kme3: 1.5610
21, and H3K18ac: 3.7610
21). As
the responding regions act as enhancers in myotubes, such
observations point to these histone marks as being activating.
While not statistically significant, increases in H3K12Ac peak
overlaps were observed in responding regions (p-
value=7.8610
22), whereas decreases were observed in non-
responding regions (p-value=1.7610
23). Differences between the
properties of the validated and reference regions were observed in
some cases (e.g. H4K12Ac), which may reflect the previously
mentioned promoter proximity of the later set. There is some
decrease in the number of responding regions with H3K27me3
marks from myoblasts to myotubes (p-value=5.8610
22), whereas
there is little change in the non-responding regions (p-
value=7.2610
21). H3K27me3 histone marks are known to play
important roles in repression of muscle-specific genes in
proliferating cells. If we look at the reference set and the
validated set separately, we observe that most only the reference




We generated genome-wide predictions of muscle-specific
CRMs using three CRM prediction programs, including Clus-
ter-Buster, LRA and MSCAN. Based on the predictions, 339
Table 7. Sequence conservation based on phastCons scores (28-way Placental Mammals).
Region Set Mean Score Avg. Max Score Conserved Region Make-Up
All Positives 0.20 0.84 18.9%
Positives from Background Set 0.12 0.74 7.9%
Positives from Non-Background Sets 0.22 0.87 21.2%
All Non-Responding Regions 0.17 0.77 15.1%
Non-Responding Regions from Background Set 0.22 0.87 18.4%
Non-Responding Regions from Non-Background Sets 0.16 0.75 14.4%
Column ‘Mean Score’ refers to the overall mean of the mean scores for each region in each set, while ‘Avg. Max Score’ refers to the mean of the highest score for each
region in each set. ‘Conserved Region Make-Up’ lists the summed conserved region lengths (identified as sub-regions with phastCons score over 0.7) divided by the sum
of the lengths of all regions in each set.
doi:10.1371/journal.pcbi.1002256.t007
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reporter gene assays in a cell culture model of skeletal muscle
development, of which 278 were successfully transfected into cells
and had reporter expression measurements taken. The validation
process revealed 19 myotube-restricted promoter-enhancing
sequences. In addition to the known enrichment for sequence
Figure 3. Examples of positive regions. Muscle TFBS hits (threshold of 80%) and the phastCons conservation profile for the region are shown as
well. When square brackets are shown, they indicate the original CRM prediction. a) Positive sequence from the muscle set. The muscle-specific TFBS
are located in regions of high sequence conservation. b) Positive sequence from the non-muscle. This sequence showed the most consistent increase
in reporter expression, with all 12 replicates determined as significantly up-regulated in muscle. c) Positive sequence from the background set.
Despite the clear cluster of muscle-specific TFBS located in the region of high sequence conservation, none of the CRM prediction tools could classify
this as a muscle CRM.
doi:10.1371/journal.pcbi.1002256.g003
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PLoS Computational Biology | www.ploscompbiol.org 11 December 2011 | Volume 7 | Issue 12 | e1002256Figure 4. Phylogenetic depth analysis of TFBSs in responding and non-responding regions using phyloP (46-way, hg19). The x-axis
grouping indicates the species used to calculate the phyloP scores. TFBSs were searched using all vertebrate profiles from the JASPAR CORE
collection using the threshold of 0.8. TFs with at least 2-fold increase in phyloP scores (46wayAll) in the TFBS positions over the non-TFBS positions in
the responding regions were identified. The score ratios for these TFs were compared among the three region sets. a) Average phyloP scores for the
predicted TFBS positions and non-TFBS positions in each region set. b) Ratios of phyloP scores for the TFBS positions and non-TFBS positions in each
region set.
doi:10.1371/journal.pcbi.1002256.g004
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revealed that the individual TFBSs display even higher sequence
conservation than the surrounding sequence. The active CRMs
exhibited elevated G/C mononucleotide content indicating the
value for including sequence composition measures in the
implementation of future methods. Comparison of the ChIP-Seq
results for MyoD and histone modification marks in C2C12 cells
with the identified enhancing sequences further supports their
recognized utility in the detection of active, functional CRMs.
The performance of the CRM prediction programs used in this
paper was not sufficient for genome annotation. The poor
performance is likely reflective of the incomplete information
presented for the prediction – the primary sequence and
sequence conservation data does not convey information about
the three dimensional properties of the nucleus nor the epigenetic
state of the chromatin [60–63]. As evidenced by the significant
increase in the proportion of responding regions that overlap with
MyoD and histone modification peaks from ChIP-Seq studies,
incorporating the results from ChIP-Seq assays for the relevant
TFs, co-activating proteins or histone modification marks can
improve the specificity of the predictions. In order for such data
to be useful, data needs to be generated for each tissue type
analyzed, as CRMs are anticipated to be differentially marked
when activated. At this time, there is an insufficient amount of
such large scale data available to make this a feasible strategy for
many tissue types, but more complete data may become available
as the costs of experiments come down and sensitivity increases.
Ultimately an intersection of computational and experimental
methods will be required for the highest quality annotation of
CRMs.
A fundamental question arising out of the work reported here is
why methods that appeared to be doing well for skeletal muscle
CRM discovery failed to demonstrate strong predictive capacity in
application here. One key reason may be driven by selection bias
for laboratory studies. The reports of CRMs from individual gene
studies may in many cases have been influenced by the
identification of muscle-related motifs in the available genomic
sequences. Due to the selective publication of those sequences
showing positive expression, the relative importance of motif
enrichment may have been over emphasized. Another key
limitation is that most of the methods generate sufficiently high
false prediction rates that the reliability of any specific set of
predictions is unlikely to be high. The results here demonstrate the
Table 8. Regions overlapping MyoD ChIP-Seq peaks in C2C12
cells.
Myoblasts Myotubes P-value
Responding 27.9% (12/43) 58.1% (25/43) 4.3E-03
Non-responding 11.6% (23/199) 15.6% (31/199) 1.5E-01
P-value 8.4E-03 3.0E-08
P-values were calculated using Fisher exact tests.
doi:10.1371/journal.pcbi.1002256.t008
Figure 5. Histone modifications in the responding and non-responding regions. Proportion of the regions that overlap with ChIP-Seq
peaks from Asp et al. are displayed. (MB=Myoblasts, MT=Myotubes).
doi:10.1371/journal.pcbi.1002256.g005
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predictions whenever feasible.
One striking observation emerging from this study is the
enrichment of G/C mononucleotides in the CRMs, observed
both in the new muscle set as well as the brain-directing CRMs
from the Pleiades Project [29]. The potential contribution of
compositional properties to regulatory regions has been previ-
ously explored, including a statistical method for CRM prediction
[64] and a recent approach from Evans to classify CRM-
containing regions into compositional subsets of genome
sequences [65]. These approaches and the data presented here
are independent of the long-recognized role of CpG islands in
demarcating promoter-containing regions and the influence of
CpG enrichment on motif over-representation [66,67]. While
there have been prediction methods released, such as Stubb,
EMMA and PhylCRM, that directly incorporate phylogenetic
footprinting in order to reduce the false positive rate of their
predictions [21,22,68], the joint incorporation of nucleotide
composition properties and sequence conservation remains to be
explored.
The outcomes of this paper include both a novel set of 19
skeletal muscle-directing CRMs for use in future machine
learning procedures and the specific call for the inclusion of
nucleotide composition properties in the next generation of
tools.
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